跳至主要内容
临床试验/IRCT20190428043409N1
IRCT20190428043409N1尚未招募3 期

Effect of Crocus sativus stigma ethanolic extract on cognitive criteria, anti-inflammatory and antioxidant markers in Nesyan patients (Alzheimer's disease)

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65 years 至 no limit(—)
性别
All

入选标准

  • 1) Man and woman Patients older than 65 years (Late Onser Alzheimer Disease)
  • Diagnosis of dementia based on DSM5 criteria and diagnosis of neurologist (confirmation with brain MRI and blood tests to exclude other causes)
  • 3. Mild to moderate Alzheimer disease based on the MMSE cognitive test score between 11 and 24

排除标准

  • Reversible dementias include delirium, pharmacotic agents, endocrine causes (hypothyroidism), metabolic causes, electrolyte, SOL, infections (encephalitis, syphilis, and AIDS) and atherosclerosis.
  • irreversible cortical causes including fronto-temporal and lewy body dementia.
  • irreversible subcortical causes include degenerative causes (such as corticobasal ganglia), inflammatory causes (such as lupus, vasculitis and multiple sclerosis)
  • The cases that change the anti-inflammatory criteria of a person, such as fever, acute infectious diseases, vasculitis, antioxidant medications, anti-inflammatory drugs such as corticosteroids (such as asthma, rheumatoid arthritis, etc.)
  • Patients with any other psychological or neurological disease based on DSM5 criteria.
  • People with MMSE score higher than 24 (MCI) and below 11 (severe dementia) do not enter the study.

研究者

相似试验

effect of saffron on dementia | 临床试验